Press Releases

SMi Group is proud to announce the return of Europe’s only Parallel Trade event conference, returning to Central London on 6th& 7th February 2018. The meeting will gather 90+ senior…
Read More...

SMi Reports: SMi’s 2nd annual Drug Discovery conference,taking place in London on 21st and 22nd March 2018, will discuss the role of artificial intelligence in drug discovery ‘The…
Read More...

Social Media in the Pharmaceutical Industry will address questions on how to engage patients with an effective social media strategy,look into understanding behavioural and emotional…
Read More...

SMi are thrilled to welcome Dr. Noreen Roth Henig, Chief Medical Officer, ProQR Therapeutics onto the speaker panel RNA Therapeutics 2018! ProQR is dedicated to discovering and…
Read More...

SMi Group are proud to present the 9th Annual RNA Therapeutics conference, taking place on 21st - 22nd February 2018 at Holiday Inn Kensington Forum, London,…
Read More...

Have you seen the complete agenda for the 10th annual Social Media in the Pharmaceutical Industry? Bringing in voices from top pharma companies and social media experts, to educate,…
Read More...

Next January in San Francisco LEAP HR will host a 2 day forum for progressive HR leaders from the world of bio pharma to totally rethink the people strategies needed in this…
Read More...

Transgene and Randox have entered into a collaboration to combine their technologies and develop multifunctional oncolytic immunotherapies. Innovative oncolytic viruses (OVs) resulting…
Read More...

MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and…
Read More...

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Dimension Therapeutics, Inc. announced…
Read More...

Aytu BioScience, Inc., a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced that the company has entered into a…
Read More...

Natus Medical Incorporated announced that it has entered into a definitive agreement with Integra LifeSciences Holdings Corporation (NASDAQ:IART) under which Natus will acquire certain…
Read More...

Building on decades of innovation in vaccine development and immunization, PATH announced today it has received a $120 million grant from the Bill & Melinda Gates Foundation to…
Read More...

Bioverativ and Bicycle Therapeutics announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell…
Read More...

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, announced a…
Read More...

Hikma Pharmaceuticals PLC announces that through its wholly owned subsidiary Hikma Pharmaceuticals LLC, it has agreed to expand its licensing and distribution agreement with Takeda…
Read More...

Johnson & Johnson Private Limited announced a new partnership with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and Industrial Research (CSIR),…
Read More...

Jounce Therapeutics, Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient enrichment, today…
Read More...

Bristol-Myers Squibb Company and IFM Therapeutics (IFM) announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the…
Read More...

Takeda Pharmaceutical Company Limited and Molecular Templates, Inc. today announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply…
Read More...